Salamanca man charged with murder in city
Breaking News
Salamanca man charged with murder in city
September 27, 2025
SALAMANCA — A Salamanca man was being held for the murder of another person in the city, Salamanca police reported Saturday. Andrew C. Skye, 35, of 31...
Home Online Features Ivonescimab Receives NMPA Approval for First-Line Treatment of PD-L1-Positive NSCLC, Based on Breakthrough Head to Head Phase III Trial Demonstrating Superior Efficacy Over Pembrolizumab
Ivonescimab Receives NMPA Approval for First-Line Treatment of PD-L1-Positive NSCLC, Based on Breakthrough Head to Head Phase III Trial Demonstrating Superior Efficacy Over Pembrolizumab
Press Releases
Akeso, Inc.  
April 25, 2025

Ivonescimab Receives NMPA Approval for First-Line Treatment of PD-L1-Positive NSCLC, Based on Breakthrough Head to Head Phase III Trial Demonstrating Superior Efficacy Over Pembrolizumab

HONG KONG, April 25, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is excited to announce that its globally first-in-class PD-1/VEGF bispecific antibody, ivonescimab, has received approval from

logo salamanca press

Salamanca Press

email salamanca press
Local & Social